Platelet neuropeptide y is critical for ischemic revascularization in mice

FASEB Journal

Volumn 27, Issue 6, 2013, Pages 2244-2255

  Tilan, Jason U ^a,b   Everhart, Lindsay M ^a   Abe, Ken ^a   Kuo Bonde, Lydia ^a   Chalothorn, Dan ^d   Kitlinska, Joanna ^a,c   Burnett, Mary Susan ^e   Epstein, Stephen E ^e   Faber, James E ^d   Zukowska, Zofia ^a,f  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e MEDSTAR RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; NPY

Indexed keywords

NEUROPEPTIDE Y;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BLOOD FLOW; CELL PROLIFERATION; CONDUCTANCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIMB; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVASCULARIZATION; THROMBOCYTE;

ANGIOGENESIS; NPY;

ANIMALS; BLOOD PLATELETS; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HINDLIMB; HUMANS; ISCHEMIA; MALE; MICE; MICE, 129 STRAIN; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROPEPTIDE Y; RATS; RATS, WISTAR;

MUS; RATTUS; RODENTIA;

EID: 84878754586     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-213546     Document Type: Article

References (67)

1. Schaper, W. (2009) Collateral circulation: past and present. Basic Res. Cardiol. 104, 5-211
2. Scholz, D., Ito, W., Fleming, I., Deindl, E., Sauer, A., Wiesnet, M., Busse, R., Schaper, J., and Schaper, W. (2000) Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch. 436, 257-2700
3. Potente, M., Gerhardt, H., and Carmeliet, P. (2011) Basic and therapeutic aspects of angiogenesis. Cell 146, 873-8877
4. Murakami, M., Nguyen, L. T., Hatanaka, K., Schachterle, W., Chen, P. Y., Zhuang, Z. W., Black, B. L., and Simons, M. (2011) FGF-dependent regulation of VEGF receptor 2 expression in mice. J. Clin. Invest. 121, 2668-26788
5. Lee, E. W., Michalkiewicz, M., Kitlinska, J., Kalezic, I., Switalska, H., Yoo, P., Sangkharat, A., Ji, H., Li, L., Michalkiewicz, T., Ljubisavljevic, M., Johansson, H., Grant, D. S., and Zukowska, Z. (2003) Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J. Clin. Invest. 111, 1853-18622
6. Torres-Vazquez, J., Gitler, A. D., Fraser, S. D., Berk, J. D., Van, N. P., Fishman, M. C., Childs, S., Epstein, J. A., and Weinstein, B. M. (2004) Semaphorin-plexin signaling guides patterning of the developing vasculature. Dev. Cell. 7, 117-1233
7. Carmeliet, P., and Tessier-Lavigne, M. (2005) Common mechanisms of nerve and blood vessel wiring. Nature 436, 193-2000
8. Chalothorn, D., Zhang, H., Clayton, J. A., Thomas, S. A., and Faber, J. E. (2005) Catecholamines augment collateral vessel growth and angiogenesis in hindlimb ischemia. Am. J. Physiol. Heart Circ. Physiol. 289, H947-H9599
9. Vecchione, C., Fratta, L., Rizzoni, D., Notte, A., Poulet, R., Porteri, E., Frati, G., Guelfi, D., Trimarco, V., Mulvany, M. J., Agabiti-Rosei, E., Trimarco, B., Cotecchia, S., and Lembo, G. (2002) Cardiovascular influences of alpha1b-adrenergic receptor defect in mice. Circulation 105, 1700-17077
10. Hu, Z. W., Shi, X. Y., Lin, R. Z., Chen, J., and Hoffman, B. B. (1999) Alpha1-adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinase. J. Pharmacol. Exp. Ther. 290, 28-377
11. Zukowska-Grojec, Z., Karwatowska-Prokopczuk, E., Rose, W., Rone, J., Movafagh, S., Ji, H., Yeh, Y., Chen, W. T., Kleinman, H. K., Grouzmann, E., and Grant, D. S. (1998) Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ. Res. 83, 187-1955
12. Herzog, H. (2003) Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models. Eur. J. Pharmacol. 480, 21-299
13. Pons, J., Kitlinska, J., Ji, H., Lee, E. W., and Zukowska, Z. (2003) Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. Can. J. Physiol. Pharmacol. 81, 177-1855
14. Ericsson, A., Schalling, M., McIntyre, K. R., Lundberg, J. M., Larhammar, D., Seroogy, K., Hokfelt, T., and Persson, H. (1987) Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice. Proc. Natl. Acad. Sci. U. S. A. 84, 5585-55899
15. Hancock, V., Martin, J. F., and Lelchuk, R. (1993) The relationship between human megakaryocyte nuclear DNA content and gene expression. Br. J. Haematol. 85, 694-6977
16. Myers, A. K., Torres Duarte, A. P., and Zukowska-Grojec, Z. (1993) Immunoreactive neuropeptide Y (NPY) in plasma and platelets of rat and mouse strains and human volunteers. Regul. Pept. 47, 239-2455
17. Myers, A. K., Farhat, M. Y., Vaz, C. A., Keiser, H. R., and Zukowska-Grojec, Z. (1988) Release of immunoreactive-neuropeptide by rat platelets. Biochem. Biophys. Res. Commun. 155, 118-1222
18. Li, L., Najafi, A. H., Kitlinska, J. B., Neville, R., Laredo, J., Epstein, S. E., Burnett, M. S., and Zukowska, Z. (2011) Of mice and men: neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability. J. Cardiovasc. Trans. Res. 4, 351-3622
19. Pinedo, H. M., Verheul, H. M., D'Amato, R. J., and Folkman, J. (1998) Involvement of platelets in tumour angiogenesis? Lancet 352, 1775-17777
20. Amano, H., Hackett, N. R., Rafii, S., and Crystal, R. G. (2005) Thrombopoietin gene transfer-mediated enhancement of angiogenic responses to acute ischemia. Circ. Res. 97, 337-3455
21. Iba, O., Matsubara, H., Nozawa, Y., Fujiyama, S., Amano, K., Mori, Y., Kojima, H., and Iwasaka, T. (2002) Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 106, 2019-20255
22. Kondoh, K., Koyama, H., Miyata, T., Takato, T., Hamada, H., and Shigematsu, H. (2004) Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor. Cardiovasc. Res. 61, 132-1422
23. Hershey, J. C., Baskin, E. P., Glass, J. D., Hartman, H. A., Gilberto, D. B., Rogers, I. T., and Cook, J. J. (2001) Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. Cardiovasc. Res. 49, 618-6255
24. Ekstrand, A. J., Cao, R., Bjorndahl, M., Nystrom, S., Jonsson- Rylander, A. C., Hassani, H., Hallberg, B., Nordlander, M., and Cao, Y. (2003) Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc. Natl. Acad. Sci. U. S. A. 100, 6033-60388
25. Kitlinska, J., Lee, E. W., Movafagh, S., Pons, J., and Zukowska, Z. (2002) Neuropeptide Y-induced angiogenesis in aging. Peptides 23, 71-777
26. Lu, C., Tilan, J. U., Everhart, L., Czarnecka, M., Soldin, S. J., Mendu, D. R., Jeha, D., Hanafy, J., Lee, C. K., Sun, J., Izycka- Swieszewska, E., Toretsky, J. A., and Kitlinska, J. (2011) Dipeptidyl peptidases as survival factors in ewing sarcoma family of tumors: implications for tumor biology and therapy. J. Biol. Chem. 286, 27494-275055
27. Lu, C., Everhart, L., Tilan, J., Kuo, L., Sun, C. C., Munivenkatappa, R. B., Jonsson-Rylander, A. C., Sun, J., Kuan-Celarier, A., Li, L., Abe, K., Zukowska, Z., Toretsky, J. A., and Kitlinska, J. (2010) Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy. Oncogene 29, 5630-56422
28. Kitlinska, J., Abe, K., Kuo, L., Pons, J., Yu, M., Li, L., Tilan, J., Everhart, L., Lee, E. W., Zukowska, Z., and Toretsky, J. A. (2005) Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Res. 65, 1719-17288
29. Cruze, C. A., Su, F., Limberg, B. J., Deutsch, A. J., Stoffolano, P. J., Dai, H. J., Buchanan, D. D., Yang, H. T., Terjung, R. L., Spruell, R. D., Mittelstadt, S. W., and Rosenbaum, J. S. (2007) The Y2 receptor mediates increases in collateral-dependent blood flow in a model of peripheral arterial insufficiency. Peptides 28, 269-2800
30. Robich, M. P., Matyal, R., Chu, L. M., Feng, J., Xu, S. H., Laham, R. J., Hess, P. E., Bianchi, C., and Sellke, F. W. (2010) Effects of neuropeptide Y on collateral development in a swine model of chronic myocardial ischemia. J. Mol. Cell. Cardiol. 49, 1022-10300
31. Kinnaird, T., Stabile, E., Burnett, M. S., Shou, M., Lee, C. W., Barr, S., Fuchs, S., and Epstein, S. E. (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109, 1543-15499
32. Rutherford, R. B., Baker, J. D., Ernst, C., Johnston, K. W., Porter, J. M., Ahn, S., and Jones, D. N. (1997) Recommended standards for reports dealing with lower extremity ischemia: revised version. J. Vasc. Surg. 26, 517-5388
33. Stabile, E., Burnett, M. S., Watkins, C., Kinnaird, T., Bachis, A., la Sala, A., Miller, J. M., Shou, M., Epstein, S. E., and Fuchs, S. (2003) Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation 108, 205-2100
34. Kuter, D. J., and Rosenberg, R. D. (1995) The reciprocal relationship of thrombopoietin (c-mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 85, 2720-27300
35. Sirois, M. G., Simons, M., Kuter, D. J., Rosenberg, R. D., and Edelman, E. R. (1997) Rat arterial wall retains myointimal hyperplastic potential long after arterial injury. Circulation 96, 1291-1298
36. Westfall, T. C. (2004) Prejunctional effects of neuropeptide Y and its role as a cotransmitter. In Neuropeptide Y and Related Peptides (Michel, M., ed) pp. 137-183, Springer, Berlinn
37. Zukowska-Grojec, Z., and Vaz, A. C. (1988) Role of neuropeptide Y (NPY) in cardiovascular responses to stress. Synapse 2, 293-2988
38. Kuo, L. E., Kitlinska, J. B., Tilan, J. U., Li, L., Baker, S. B., Johnson, M. D., Lee, E. W., Burnett, M. S., Fricke, S. T., Kvetnansky, R., Herzog, H., and Zukowska, Z. (2007) Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat. Med. 13, 803-8111
39. Lundberg, J. M., Rudehill, A., Sollevi, A., Theodorsson- Norheim, E., and Hamberger, B. (1986) Frequency- and reserpine- dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci. Lett. 63, 96-1000
40. Italiano, J. E., Jr., Richardson, J. L., Patel-Hett, S., Battinelli, E., Zaslavsky, A., Short, S., Ryeom, S., Folkman, J., and Klement, G. L. (2008) Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111, 1227-12333
41. Harrison, P., and Cramer, E. M. (1993) Platelet alpha-granules. Blood Rev. 7, 52-622
42. Ferreira, R., Xapelli, S., Santos, T., Silva, A. P., Cristovao, A., Cortes, L., and Malva, J. O. (2010) Neuropeptide Y modulation of interleukin-1β (IL-1β)-induced nitric oxide production in microglia. J. Biol. Chem. 285, 41921-419344
43. Chalothorn, D., Clayton, J. A., Zhang, H., Pomp, D., and Faber, J. E. (2007) Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains. Physiol. Genomics 30, 179-1911
44. Brenes, R. A., Jadlowiec, C. C., Bear, M., Hashim, P., Protack, C. D., Li, X., Lv, W., Collins, M. J., and Dardik, A. (2012) Toward a mouse model of hind limb ischemia to test therapeutic angiogenesis. J. Vasc. Surg. 56, 1669-16799
45. Tirziu, D., Moodie, K. L., Zhuang, Z. W., Singer, K., Helisch, A., Dunn, J. F., Li, W., Singh, J., and Simons, M. (2005) Delayed arteriogenesis in hypercholesterolemic mice. Circulation 112, 2501-25099
46. Troidl, K., Tribulova, S., Cai, W. J., Ruding, I., Apfelbeck, H., Schierling, W., Troidl, C., Schmitz-Rixen, T., and Schaper, W. (2010) Effects of endogenous nitric oxide and of DETA NONOate in arteriogenesis. J. Cardiovasc. Pharmacol. 55, 153-1600
47. Wahlestedt, C., Hakanson, R., Vaz, C. A., and Zukowska-Grojec, Z. (1990) Norepinephrine and neuropeptide Y: vasoconstrictor cooperation in vivo and in vitro. Am. J. Physiol. 258, R736-7422
48. Movafagh, S., Hobson, J. P., Spiegel, S., Kleinman, H. K., and Zukowska, Z. (2006) Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. FASEB J. 20, 1924-1926
49. Schaper, W., and Schaper, J. (2004) Arteriogenesis, Kluwer Academics, Londonn
50. Hoefer, I. E., Grundmann, S., van Royen, N., Voskuil, M., Schirmer, S. H., Ulusans, S., Bode, C., Buschmann, I. R., and Piek, J. J. (2005) Leukocyte subpopulations and arteriogenesis: specific role of monocytes, lymphocytes and granulocytes. Atherosclerosis 181, 285-2933
51. Tritsaris, K., Myren, M., Ditlev, S. B., Hubschmann, M. V., van der Blom, I., Hansen, A. J., Olsen, U. B., Cao, R., Zhang, J., Jia, T., Wahlberg, E., Dissing, S., and Cao, Y. (2007) IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbs. Proc. Natl. Acad. Sci. U. S. A. 104, 15364-153699
52. Tan, Y., Shao, H., Eton, D., Yang, Z., Alonso-Diaz, L., Zhang, H., Schulick, A., Livingstone, A. S., and Yu, H. (2007) Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte- colony stimulating factor. Cardiovasc. Res. 73, 823-8322
53. Andre, P., Morooka, T., Sim, D., Abe, K., Lowell, C., Nanda, N., Delaney, S., Siu, G., Yan, Y., Hollenbach, S., Pandey, A., Gao, H., Wang, Y., Nakajima, K., Parikh, S. A., Shi, C., Phillips, D., Owen, W., Sinha, U., and Simon, D. I. (2011) Critical role for syk in responses to vascular injury. Blood 118, 5000-50100
54. Epstein, S. E., Stabile, E., Kinnaird, T., Lee, C. W., Clavijo, L., and Burnett, M. S. (2004) Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis. Circulation 109, 2826-28311
55. Li, L., Lee, E. W., Ji, H., and Zukowska, Z. (2003) Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery. Arterioscler. Thromb. Vasc. Biol. 23, 1204-12100
56. Ma, L., Perini, R., McKnight, W., Dicay, M., Klein, A., Hollenberg, M. D., and Wallace, J. L. (2005) Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc. Natl. Acad. Sci. U. S. A. 102, 216-2200
57. Sehgal, S., and Storrie, B. (2007) Evidence that differential packaging of the major platelet granule proteins von willebrand factor and fibrinogen can support their differential release. J. Thromb. Haemost. 5, 2009-20166
58. Klement, G. L., Yip, T. T., Cassiola, F., Kikuchi, L., Cervi, D., Podust, V., Italiano, J. E., Wheatley, E., Abou-Slaybi, A., Bender, E., Almog, N., Kieran, M. W., and Folkman, J. (2009) Platelets actively sequester angiogenesis regulators. Blood 113, 2835-28422
59. Brunner, G., Nguyen, H., Gabrilove, J., Rifkin, D. B., and Wilson, E. L. (1993) Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 81, 631-6388
60. Mohle, R., Green, D., Moore, M. A., Nachman, R. L., and Rafii, S. (1997) Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. U. S. A. 94, 663-6688
61. Pintucci, G., Froum, S., Pinnell, J., Mignatti, P., Rafii, S., and Green, D. (2002) Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF). Thromb. Haemost. 88, 834-8422
62. Wartiovaara, U., Salven, P., Mikkola, H., Lassila, R., Kaukonen, J., Joukov, V., Orpana, A., Ristimaki, A., Heikinheimo, M., Joensuu, H., Alitalo, K., and Palotie, A. (1998) Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb. Haemost. 80, 171-1755
63. Iruela-Arispe, M. L., Bornstein, P., and Sage, H. (1991) Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc. Natl. Acad. Sci. U. S. A. 88, 5026-50300
64. Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., and Sharpe, R. J. (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247, 77-799
65. Yamaguchi, J., Kusano, K. F., Masuo, O., Kawamoto, A., Silver, M., Murasawa, S., Bosch-Marce, M., Masuda, H., Losordo, D. W., Isner, J. M., and Asahara, T. (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107, 1322-13288
66. Holler, J., Zakrzewicz, A., Kaufmann, A., Wilhelm, J., Fuchs- Moll, G., Dietrich, H., Padberg, W., Kuncova, J., Kummer, W., and Grau, V. (2008) Neuropeptide Y is expressed by rat mononuclear blood leukocytes and strongly down-regulated during inflammation. J. Immunol. 181, 6906-69122
67. Schwarz, H., Villiger, P. M., von Kempis, J., and Lotz, M. (1994) Neuropeptide Y is an inducible gene in the human immune system. J. Neuroimmunol. 51, 53-611